Brief: Fulgent Reports Third Quarter 2024 Financial Results
08/11/2024 12:27
Nov 8 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
* FULGENT GENETICS INC: REITERATES FULL YEAR 2024 CORE
REVENUE
GUIDANCE OF $280 MILLION
* FULGENT GENETICS INC OUTLOOK FY 2024 ADJUSTED EPS $0.33
* FULGENT GENETICS INC QTRLY ADJUSTED EPS $0.31
Source text: ID:nBw5HcDW3a
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview